Proviron

PROVIRON BY XENO LABORATORIES

Tablets

DRUG COMPOSITION

1 tablet contains:
 - active substance: mesterolone 10 mg;
 - auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Androgenic Steroidal Agent.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: N/A
Routes of administration: by mouth
Dosage forms: (Men): N/A; (Women): -
Acne: n/a
Water retention: n/a
High blood pressure: n/a
Hepatotoxicity: n/a
Aromatase: n/a
Decreased HPTA function (own testosterone production): n/a
Anabolic activity: N/A
Androgenic activity: N/A
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

10 mg tablets.
50 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Xeno Laboratories
USA